Halting the Regulation of AstraZeneca for Awhile
The Philippines is briefly halting regulating AstraZeneca’s COVID-19 antibodies to those under 60 after the European Medicine Agency (EMA) found that blood coagulating joined with low platelet tally is a potential, albeit exceptionally uncommon symptom of the shot. In view of this, The Department of Health (DOH) paid attention to Thursday the Food and Drug Administration’s (FDA) suggestion to end …